730 related articles for article (PubMed ID: 8721989)
1. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
Ferrag F; Chiarenza A; Goffin V; Kelly PA
Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989
[TBL] [Abstract][Full Text] [Related]
2. Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation.
Goupille O; Daniel N; Bignon C; Jolivet G; Djiane J
Mol Cell Endocrinol; 1997 Mar; 127(2):155-69. PubMed ID: 9099911
[TBL] [Abstract][Full Text] [Related]
3. Interactions among Janus kinases and the prolactin (PRL) receptor in the regulation of a PRL response element.
Gao J; Hughes JP; Auperin B; Buteau H; Edery M; Zhuang H; Wojchowski DM; Horseman ND
Mol Endocrinol; 1996 Jul; 10(7):847-56. PubMed ID: 8813725
[TBL] [Abstract][Full Text] [Related]
4. JAK2 and STAT5, but not JAK1 and STAT1, are required for prolactin-induced beta-lactoglobulin transcription.
Han Y; Watling D; Rogers NC; Stark GR
Mol Endocrinol; 1997 Jul; 11(8):1180-8. PubMed ID: 9212064
[TBL] [Abstract][Full Text] [Related]
5. Homodimerization of IL-2 receptor beta chain is necessary and sufficient to activate Jak2 and downstream signaling pathways.
Ferrag F; Pezet A; Chiarenza A; Buteau H; Nelson BH; Goffin V; Kelly PA
FEBS Lett; 1998 Jan; 421(1):32-6. PubMed ID: 9462834
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine docking sites of the rat prolactin receptor required for association and activation of stat5.
Pezet A; Ferrag F; Kelly PA; Edery M
J Biol Chem; 1997 Oct; 272(40):25043-50. PubMed ID: 9312112
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
8. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
[TBL] [Abstract][Full Text] [Related]
9. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
10. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription.
Gouilleux F; Wakao H; Mundt M; Groner B
EMBO J; 1994 Sep; 13(18):4361-9. PubMed ID: 7925280
[TBL] [Abstract][Full Text] [Related]
11. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin.
Jabbour HN; Critchley HO; Boddy SC
J Clin Endocrinol Metab; 1998 Jul; 83(7):2545-53. PubMed ID: 9661641
[TBL] [Abstract][Full Text] [Related]
12. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G
Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters.
Luo G; Yu-Lee L
J Biol Chem; 1997 Oct; 272(43):26841-9. PubMed ID: 9341115
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of endogenous GH and interleukin-6 receptors selectively activates different Jaks and Stats, with a Stat5 specific synergistic effect of dexamethasone.
von Laue S; Finidori J; Maamra M; Shen XY; Justice S; Dobson PR; Ross RJ
J Endocrinol; 2000 May; 165(2):301-11. PubMed ID: 10810294
[TBL] [Abstract][Full Text] [Related]
15. Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of langerhans.
Brelje TC; Stout LE; Bhagroo NV; Sorenson RL
Endocrinology; 2004 Sep; 145(9):4162-75. PubMed ID: 15142985
[TBL] [Abstract][Full Text] [Related]
16. Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin.
Coss D; Kuo CB; Yang L; Ingleton P; Luben R; Walker AM
Endocrinology; 1999 Nov; 140(11):5087-94. PubMed ID: 10537136
[TBL] [Abstract][Full Text] [Related]
17. Prolactin-induced expression of cytokine-inducible SH2 signaling inhibitors in human hematopoietic progenitors.
Cwikel S; Silvian-Drachsler I; Prolov L; Hooghe-Peters EL; Merchav S
Exp Hematol; 2001 Aug; 29(8):937-42. PubMed ID: 11495699
[TBL] [Abstract][Full Text] [Related]
18. Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor.
Sotiropoulos A; Moutoussamy S; Renaudie F; Clauss M; Kayser C; Gouilleux F; Kelly PA; Finidori J
Mol Endocrinol; 1996 Aug; 10(8):998-1009. PubMed ID: 8843416
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.
Paukku K; Valgeirsdóttir S; Saharinen P; Bergman M; Heldin CH; Silvennoinen O
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):759-66. PubMed ID: 10642538
[TBL] [Abstract][Full Text] [Related]
20. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
